Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL

19 May 2008

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Lymphoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 18490915
DOI: 10.1038/bmt.2008.122

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALLPMID 18490915Read ↗

B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in ChildrenSemantic proximity Read ↗

Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoringSemantic proximity Read ↗

Engraftment and Measurable Residual Disease Monitoring after Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?Semantic proximity Read ↗

Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current managementSemantic proximity Read ↗

Importance of measurable residual disease in the outcome of adults with acute lymphoblastic leukemia after allogeneic stem cell transplantation: Long follow-up analysis from a single transplant centerSemantic proximity Read ↗

Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantationSemantic proximity Read ↗

Minimal residual disease detection by next-generation sequencing of different immunoglobulin gene rearrangements in pediatric B-ALLSemantic proximity Read ↗

Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Minimal Residual Disease Prior to and After Haematopoietic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia: What Level of Negativity Is Relevant?Semantic proximity Read ↗

Clinical utility of next‐generation sequencing‐based minimal residual disease in paediatric B‐cell acute lymphoblastic leukaemiaSemantic proximity Read ↗

B Lymphoblastic Leukemia Minimal Residual Disease Assessment by Flow Cytometric AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.